SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-006472
Filing Date
2024-05-22
Accepted
2024-05-22 17:16:54
Documents
13
Period of Report
2024-05-21
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnpx_8k-052224.htm   iXBRL 8-K 46786
  Complete submission text file 0001999371-24-006472.txt   220413

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20240521.xsd EX-101.SCH 3024
3 XBRL LABEL FILE tnxp-20240521_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tnxp-20240521_pre.xml EX-101.PRE 22365
16 EXTRACTED XBRL INSTANCE DOCUMENT tnpx_8k-052224_htm.xml XML 3544
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 24974351
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)